Anti‐D prophylaxis: past, present and future

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Transfusion Medicine

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tme.12099PMID 25121157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A missed opportunity for excellence: the NICE guideline on the diagnosis and initial management of ectopic pregnancy and miscarriage

  2014cited by this paper
• BCSH guideline for the use of anti‐D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn

  2014influential reference
• Targeted Routine Antenatal Anti-D Prophylaxis in the Prevention of RhD Immunisation - Outcome of a New Antenatal Screening and Prevention Program

  2013cited by this paper
• Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.

  2012cited by this paper
• Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxis

  2012cited by this paper
• Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA

  2012cited by this paper
• Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience

  2012cited by this paper
• Management and Prevention of Red Cell Alloimmunization in Pregnancy: A Systematic Review

  2012cited by this paper
• Pharmacokinetics and safety of roledumab, a novel human recombinant monoclonal anti‐RhD antibody with an optimized Fc for improved engagement of FCγRIII, in healthy volunteers

  2012cited by this paper
• The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma

  2011cited by this paper
• Report of the Fourth International Workshop on molecular blood group genotyping

  2011cited by this paper
• Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7‐year clinical experience

  2011cited by this paper
• Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.

  2010cited by this paper
• Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.

  2009cited by this paper
• GUIDELINES FOR USE

  2009cited by this paper
• Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008

  2009cited by this paper
• One single dose of 200 μg of antenatal RhIG halves the risk of anti‐D immunization and hemolytic disease of the fetus and newborn in the next pregnancy

  2008cited by this paper
• Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study

  2008cited by this paper
• Workshop report on the extraction of foetal DNA from maternal plasma

  2007cited by this paper
• Evaluation of prenatal RHD typing strategies on cell‐free fetal DNA from maternal plasma

  2006cited by this paper
• On the immunologic basis of Rh immune globulin (anti‐D) prophylaxis

  2006cited by this paper
• On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.

  2006cited by this paper
• Guidelines for the use of prophylactic anti-D immunoglobulin

  2006cited by this paper
• Non-invasive antenatal RHD typing.

  2006cited by this paper
• Report of the Third International Workshop on Molecular Blood Group Genotyping

  2005cited by this paper
• Current status of immunoprophylaxis with anti-D immunoglobin.

  2003cited by this paper
• International Forum: 1

  2003cited by this paper
• A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.

  2003cited by this paper
• Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service

  2002cited by this paper
• RhD haemolytic disease of the fetus and the newborn.

  2000cited by this paper
• Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study

  1999cited by this paper
• Recommendations for the use of anti‐D immunoglobulin for Rh prophylaxis

  1999cited by this paper
• Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.

  1998cited by this paper
• Detection of fetal RHD-specific sequences in maternal plasma.

  1998cited by this paper
• Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

  1998cited by this paper
• Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme

  1997cited by this paper
• Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

  1989cited by this paper
• [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].

  1987cited by this paper
• The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.

  1983cited by this paper
• Prevention of Rh isoimmunization by injection of anti-D antibody.

  1967cited by this paper
• The pathogenesis and prevention of Rh immunization.

  1967cited by this paper

• A survey on the use of Rh immune globulin during a nationwide shortage

  2025cites this paper
• Neonatal Exchange Transfusion in a Transitioning Healthcare System: A 23-Year National Trends Analysis from Serbia.

  2025cites this paper
• Perinatal outcomes in RhD-negative pregnant women in Japan

  2025cites this paper
• Digital Dialogs on Rhesus Incompatibility: A Thematic Analysis of Web-Based Parental Narratives

  2025cites this paper
• Noninvasive fetal blood group antigen genotyping

  2024cites this paper
• RhD alloimmunization – diagnostics, therapy and prophylaxis

  2024influential citation
• Standard Compared With Extended Red Blood Cell Antigen Matching for Prevention of Subsequent Hemolytic Disease of the Fetus and Newborn

  2024cites this paper
• Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.

  2024cites this paper
• Prevalence of Rhesus D negativity and barriers to immuno- prophylaxis among obstetric patients in Kitengela Sub- county Hospital: A cross-sectional study

  2024cites this paper
• Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden.

  2024cites this paper
• Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D– pregnant women

  2024cites this paper
• Non-RhD alloimmunization in pregnancy: an updated review

  2024cites this paper
• The influence of HLA allele and haplotype on RhE alloimmunization among pregnant females in the Chinese Han population

  2024cites this paper
• Hereditary TTP/Upshaw–Schulman syndrome: the ductus arteriosus controls newborn survival

  2024cites this paper
• Prevalence of unexpected red blood cell antibodies in pregnant women and follow-up of pregnancy outcome in pregnant women treated with intra-uterine transfusion

  2024influential citation
• DIAGNOSTIC PITFALLS OF HEMOLYTIC ANEMIA DURING THE NEWBORN PERIOD: FETO-MATERNAL KG-BLOOD TYPE INCOMPATIBILITY AND HEREDITARY TTP/UPSHAW-SCHULMAN SYNDROME

  2024cites this paper
• Red Blood Cell Alloimmunization Prevention Practices in Pregnancy at Tertiary Care Level Hospitals in Islamabad, Pakistan: a Cross-sectional Study

  2023cites this paper
• Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy.

  2023cites this paper
• Post-marketing safety evaluation of recombinant anti-rho (D) immunoglobulin for the prevention of maternal rh-isoimmunization: A prospective, multi-centre, phase IV study

  2023cites this paper
• Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression.

  2023cites this paper
• Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland

  2023cites this paper
• Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010

  2023cites this paper
• Single‐exon approach to non‐invasive fetal RHD screening in early pregnancy: An update after 10 years' experience

  2022cites this paper
• Routine noninvasive prenatal screening for fetal Rh D in maternal plasma—A 2‐year experience from a single center in Belgium

  2022cites this paper
• Management of Rh-negative Alloimmunized Pregnancy Optimizing Perinatal Mortality and Morbidity: A Single-center Study

  2022cites this paper
• Assessment and management of vaginal bleeding in early pregnancy

  2022cites this paper
• Update on the Use of Intravenous Immunoglobulin in Pregnancy.

  2021cites this paper
• Practices for RhD alloimmunization prevention: a vignette-based survey of midwives

  2021cites this paper
• Recommendation for validation and quality assurance of non‐invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations

  2021cites this paper
• Dangers of Relaxed Restrictions on Mifepristone

  2021cites this paper
• Algorithm development and diagnostic accuracy testing for non-invasive foetal RHD genotyping: an Indian experience.

  2021cites this paper
• Maternal bleeding complications in pregnancies affected by red blood cell alloimmunization.

  2021cites this paper
• Prenatal RHD genotyping in Croatia: preliminary results.

  2020cites this paper
• External quality assessment of noninvasive fetal RHD genotyping

  2020cites this paper
• Infants affected by Rh sensitization: A 2-year Canadian National Surveillance Study.

  2020cites this paper
• Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children

  2020cites this paper
• Two Reliable Methodical Approaches for Non-Invasive RHD Genotyping of a Fetus from Maternal Plasma

  2020cites this paper
• Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management

  2020cites this paper
• RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates.

  2020cites this paper
• Hemolytic Disease of the Fetus and Newborn

  2019cites this paper
• Amplicon Sequencing-Based Noninvasive Fetal Genotyping for RHD-Positive D Antigen-Negative Alleles.

  2019cites this paper
• Alloimmunization and Role of HLA in Pregnancy

  2019cites this paper
• Introduction of Noninvasive Prenatal Testing for Blood Group and Platelet Antigens from Cell-Free Plasma DNA Using Digital PCR

  2019cites this paper
• Noninvasive fetal RHD genotyping to guide targeted anti‐D prophylaxis–an external quality assessment workshop

  2019cites this paper
• How clinically important are non‐D Rh antibodies?

  2019cites this paper
• Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.

  2018cites this paper
• Red Blood Cell Alloimmunization in the Pregnant Patient.

  2018cites this paper
• Determination of fetal RHD type in plasma of RhD negative pregnant women

  2018cites this paper
• Lessons learned from the implementation of non-invasive fetal RHD screening

  2018cites this paper
• Noninvasive prenatal HPA‐1 typing in HPA‐1a negative pregnancies selected in the Polish PREVFNAIT screening program

  2018cites this paper
• Non-invasive foetal RhD genotyping to guide anti-D prophylaxis: an external quality assurance workshop.

  2018cites this paper
• Retrospective analysis of 55 twin neonates with haemolytic disease of the newborn

  2017cites this paper
• [Anti-D prophylaxis in fetal-maternal erythrocyte incompatibility in Tunisia].

  2017cites this paper
• Prevention of Rh D Alloimmunization

  2017cites this paper
• Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.

  2017cites this paper
• Practice Bulletin No. 181 Summary: Prevention of Rh D Alloimmunization.

  2017cites this paper
• Prevention of Rh D Alloimmunization

  2017cites this paper
• Hemolytic disease of the fetus and newborn in the molecular era.

  2016cites this paper
• CA 2-238: PROFILAXIS EN ISOINMUNIZACIÓN RH. INNOVACIÓN EN SEGURIDAD MATERNO-INFANTIL

  2016cites this paper
• Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.

  2016cites this paper
• Advances in detection of antenatal alloimmunization and its management

  2015cites this paper
• Harmless Pregnancy-Induced Warm Autoantibodies to Red Blood Cells

  2015cites this paper
• Gestörte Frühschwangerschaft – Diagnostik und Therapie

  2015cites this paper
• Haemolytic disease of the fetus and newborn

  2015cites this paper
• Considerations of red blood cell molecular testing in transfusion medicine

  2015cites this paper
• DAR boosted anti‐D HDFN in a Caucasian family

  2015cites this paper
• Routine noninvasive prenatal screening for fetal RHD in plasma of RhD‐negative pregnant women—2 years of screening experience from Denmark

  2014cites this paper
• Rhesus typing av foster basert på blodprøve fra rhesus negative gravide

  2014cites this paper
• Fetale molekulargenetische Blutgruppenbestimmung aus mütterlichem Plasma

  2014cites this paper